MAPT and Alzheimer disease: A key finding was that treatment with mitochondria-targeted antioxidants reduced hippocampal Aβ protein and tau hyperphosphorylation levels (Stefanova et al., 2019a), which demonstrates a possible causal relationship between mitochondrial function and AD.